Workflow
Price to Cash Flow (P/CF) Ratio
icon
Search documents
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
ZACKS· 2025-06-16 14:31
Market Overview - Significant turbulence in global financial markets due to escalating hostilities between Israel and Iran, particularly Israeli airstrikes on Iran's nuclear facilities [1] - Major U.S. indices experienced sharp declines, with the Dow Jones Industrial Average down 1.8% (769.81 points), S&P 500 down 1.1% (68.29 points), and Nasdaq Composite down 1.3% (255.67 points) [2] Investment Opportunities - Value stocks may become attractive during market uncertainty as they are often priced below intrinsic value, providing a margin of safety [3] - Effective valuation metric for value stocks is the Price to Cash Flow (P/CF) ratio, with companies like StoneCo Ltd. (STNE), Centene Corporation (CNC), CVS Health Corporation (CVS), and Pfizer Inc. (PFE) showing low P/CF ratios [4][10] Financial Health Metrics - P/CF ratio is preferred over Price/Earnings (P/E) as it reflects a company's financial health by adding back non-cash charges to net income [5][6] - Positive cash flow indicates increased liquidity, allowing companies to settle debts, reinvest, and undertake shareholder-friendly actions [7] Value Investing Strategy - A comprehensive investment strategy should include multiple metrics such as price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio, along with a favorable Zacks Rank and Value Score [8][12] - Parameters for selecting true-value stocks include P/CF less than or equal to industry median, minimum stock price of $5, and various other financial ratios [9][11] Company Performance Insights - StoneCo (STNE) has a Zacks Rank 1, with projected sales and EPS growth of 10.9% and 4.4% respectively, and shares have risen 15.2% in the past year [14] - Centene (CNC) holds a Zacks Rank 2, with projected sales and EPS growth of 10.1% and 1.5% respectively, but shares have declined 19.1% in the past year [14] - CVS Health (CVS) also has a Zacks Rank 2, with projected sales and EPS growth of 3.5% and 12.6% respectively, and shares have increased by 10.4% in the past year [15] - Pfizer (PFE) carries a Zacks Rank 2, with projected sales and EPS declines of 0.6% and 1.6% respectively, and shares have fallen 9.1% in the past year [16]
4 Value Picks to Ride the Market Rebound After US-China Trade Thaw
ZACKS· 2025-05-13 15:40
Wall Street saw a strong rally on Monday, driven by renewed optimism over U.S.-China trade relations. A 90-day agreement between the two nations to reduce tariffs has rekindled hopes of easing global trade tensions. The United States will lower duties on Chinese imports from a steep 145% to 30%, while China has agreed to cut its retaliatory tariffs on American goods from 125% to 10%, signaling a shift from confrontation to cooperation.Markets responded positively, with the S&P 500 jumping 3.3% to settle at ...